tiprankstipranks
Trending News
More News >
Incyte Corp (INCY)
NASDAQ:INCY
Advertisement

Incyte (INCY) Similar Stocks

Compare
1,813 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Incyte
$101.57
$19.94B
17.04
34.09%
7 Buy
10 Hold
1 Sell
Moderate Buy
BioMarin Pharmaceutical
$52.85
$10.29B
20.07
-20.65%
18 Buy
4 Hold
0 Sell
Strong Buy
Exelixis
$38.06
$10.25B
18.25
10.99%
9 Buy
5 Hold
0 Sell
Moderate Buy
United Therapeutics
$438.66
$19.18B
16.88
17.28%
9 Buy
4 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$200.98
$12.17B
-40.45
60.42%
16 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$28.71
$17.47B
14.17
26.03%
5 Buy
1 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INCY
Incyte
101.57
25.82
34.09%
BMRN
BioMarin Pharmaceutical
52.85
-13.16
-19.94%
EXEL
Exelixis
38.06
3.77
10.99%
UTHR
United Therapeutics
438.66
61.86
16.42%
ASND
Ascendis Pharma
200.98
75.21
59.80%
GMAB
Genmab
28.71
5.93
26.03%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis